Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems

Lina Steinrud Mørch, Meaidi A, Amani Meaidi, Corn G, Giulia Corn, Hargreave M, Marie Hargreave, Charlotte Wessel Skovlund, Wessel Skovlund C
JAMA · 2024 · vol. 332(18) , pp. 1578–1580 · doi:10.1001/jama.2024.18575 · PMID:39412770 · PMC11558473
Other OA: closed
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-28 ⓘ

This paper investigates the incidence of breast cancer among users of levonorgestrel-releasing intrauterine systems, though specific findings are not provided in the available source material.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
pubmed
last seen: 2026-10-08T21:46:11.266357+00:00